This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Hypertension  • Alert me on articles by topic

Arch Intern Med. 2003;163:521-522.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

TREATMENT OF elevated blood pressure has been shown to reduce the risk of death and disability for groups of patients with hypertension. However, because we have not yet learned how to focus our prevention and treatment efforts on the individual patients most likely to experience the negative health consequences, we treat millions of people at relatively low risk of serious consequences so as not to miss treating those at high risk.

Elaboration of the human genome has resulted in the discovery of many polymorphisms of specific human genes related to the pathophysiology of hypertension and holds the promise of a method to identify those people most at risk. Unfortunately, the important discoveries made to date apply only to a very small number of people. Combinations of gene polymorphisms such as reported by Staessen et al¹ show potential, but this work is extraordinarily time-consuming, and the findings may not apply to . . . [Full Text of this Article]

RELATED ARTICLE

Management of High Blood Pressure in African Americans: Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks
Janice G. Douglas, George L. Bakris, Murray Epstein, Keith C. Ferdinand, Carlos Ferrario, John M. Flack, Kenneth A. Jamerson, Wendell E. Jones, Julian Haywood, Randall Maxey, Elizabeth O. Ofili, Elijah Saunders, Ernesto L. Schiffrin, Domenic A. Sica, James R. Sowers, Donald G. Vidt, and the Hypertension in African Americans Working Group
Arch Intern Med. 2003;163(5):525-541.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Variability in Response to Antihypertensive Drug Treatment
Materson
Hypertension 2004;43:1166-1167.
FULL TEXT  

Determinants of Blood Pressure Response to Quinapril in Black and White Hypertensive Patients: The Quinapril Titration Interval Management Evaluation Trial
Mokwe et al.
Hypertension 2004;43:1202-1207.
ABSTRACT | FULL TEXT